Intercure Ltd. (INCR) stock
INCRNasdaqPharmaceutical PreparationsFiscal year ends December 31
$3.61−0.02 (-0.55%)
Close on Nov 17, 2026Market cap $197.40MP/E –Yield –
Intercure operating income
Operating income is the profit from the core business after operating expenses such as R&D and selling costs, before interest and taxes.
For fiscal 2025 it was -27.24M ILS. The highest annual figure on record is 50.63M ILS in fiscal 2022.
Annual operating income
| Period | Period end | Value | Change |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | -27.24M ILS | – |
| FY2024 | Dec 31, 2024 | -67.21M ILS | – |
| FY2023 | Dec 31, 2023 | -41.57M ILS | -182.1% |
| FY2022 | Dec 31, 2022 | 50.63M ILS | +79.6% |
| FY2021 | Dec 31, 2021 | 28.19M ILS | – |
| FY2020 | Dec 31, 2020 | -38.40M ILS | – |
| FY2019 | Dec 31, 2019 | -3.42M ILS | – |
See a number that looks wrong?